By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Merrimack Pharmaceuticals Inc. 

101 Binney Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-441-1000 Fax: 617-491-1386


SEARCH JOBS



Segment
Start Up

Collaborations

Dyax Corp.  Antibody phage display





Company News
Merrimack Pharmaceuticals Inc. (MACK) Presents On Multiple Programs At The 26th European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium On Molecular Targets And Cancer Therapeutics 11/21/2014 2:46:31 PM
PharmaEngine Announces The Receipt Of US FDA Fast Track Designation For MM-398 In Post-Gemcitabine Metastatic Pancreatic Cancer By Merrimack Pharmaceuticals Inc. (MACK) 11/20/2014 5:53:40 AM
Merrimack Pharmaceuticals Inc. (MACK) Receives FDA Fast Track Designation For MM-398 In Post-Gemcitabine Metastatic Pancreatic Cancer 11/19/2014 9:22:59 AM
Photo Release -- Merrimack Pharmaceuticals Inc. (MACK) Announces The Addition Of Vivian S. Lee, Dean Of University Of Utah School Of Medicine, To Its Board Of Directors 11/17/2014 2:42:24 PM
Merrimack Pharmaceuticals Inc. (MACK) To Present Advances On Targeted Cancer Molecules At The 2014 American Association for Cancer Research-National Cancer Institute-European Organization for Research and Treatment of Cancer International Conference 11/14/2014 10:14:09 AM
Merrimack Pharmaceuticals Inc. (MACK) Reports Third Quarter 2014 Financial Results 11/11/2014 7:55:10 AM
Merrimack Pharmaceuticals Inc. (MACK) Announces Initiation Of Phase 1 Clinical Study Of MM-398 For Brain Cancer 11/6/2014 7:21:09 AM
FDA Grants Orphan Drug Designation To Merrimack Pharmaceuticals Inc. (MACK)' MM-141 For The Treatment Of Pancreatic Cancer 11/5/2014 7:21:52 AM
Merrimack Pharmaceuticals Inc. (MACK) Announces Timing Of Third Quarter 2014 Investor Conference Call 11/3/2014 8:38:56 AM
Merrimack Pharmaceuticals Inc. (MACK) Presents Additional Phase 2 Biomarker Data Further Strengthening The Finding That MM-121 Increases Progression Free Survival In Patients With Biomarker Positive Metastatic Breast Cancer 9/30/2014 7:40:45 AM
12345678910...
//-->